157 related articles for article (PubMed ID: 32801284)
21. Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High-Dose Methotrexate.
Drost SA; Wentzell JR; Giguère P; McLurg DL; Sabloff M; Kanji S; Nguyen TT
Pharmacotherapy; 2017 Jun; 37(6):684-691. PubMed ID: 28394433
[TBL] [Abstract][Full Text] [Related]
22. Plasma and urine levels of methotrexate and 7-hydroxymethotrexate in children with ALL during maintenance therapy with weekly oral methotrexate.
Skoglund KA; Söderhäll S; Beck O; Peterson C; Wennberg M; Hayder S; Björk O
Med Pediatr Oncol; 1994; 22(3):187-93. PubMed ID: 8272008
[TBL] [Abstract][Full Text] [Related]
23. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.
Schwartz S; Borner K; Müller K; Martus P; Fischer L; Korfel A; Auton T; Thiel E
Oncologist; 2007 Nov; 12(11):1299-308. PubMed ID: 18055849
[TBL] [Abstract][Full Text] [Related]
24. UPLC-MS/MS Analysis of Methotrexate in Human Plasma and Comparison with the Fluorescence Polarization Immunoassay.
Mei S; Zhu L; Li X; Wang J; Jiang X; Chen H; Huo J; Yang L; Lin S; Zhao Z
Anal Sci; 2017; 33(6):665-670. PubMed ID: 28603183
[TBL] [Abstract][Full Text] [Related]
25. Detection by high-performance liquid chromatography of methotrexate and its metabolites in tumor tissue from osteosarcoma patients treated with high-dose methotrexate/leucovorin rescue.
Samuels LL; Feinberg A; Moccio DM; Sirotnak FM; Rosen G
Biochem Pharmacol; 1984 Sep; 33(17):2711-4. PubMed ID: 6205660
[TBL] [Abstract][Full Text] [Related]
26. Analysis of methotrexate and 7-hydroxymethotrexate by high-pressure liquid chromatography.
Wisnicki JL; Tong WP; Ludlum DB
Cancer Treat Rep; 1978 Apr; 62(4):529-32. PubMed ID: 657149
[TBL] [Abstract][Full Text] [Related]
27. Maximum tolerated doses of methotrexate and 7-hydroxy-methotrexate in a model of acute toxicity in rats.
Fuskevåg OM; Kristiansen C; Lindal S; Aarbakke J
Cancer Chemother Pharmacol; 2000; 46(1):69-73. PubMed ID: 10912581
[TBL] [Abstract][Full Text] [Related]
28. Determination of erythrocyte methotrexate polyglutamates by liquid chromatography/tandem mass spectrometry after low-dose methotrexate therapy in Chinese patients with rheumatoid arthritis.
Mo X; Wen Y; Ren B; Chen J; Xu C; Wang X; Huang M; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():41-8. PubMed ID: 22999476
[TBL] [Abstract][Full Text] [Related]
29. Development and Validation of UHPLC-MS/MS Assay for Therapeutic Drug Monitoring of High-dose Methotrexate in Children with Acute Lymphoblastic Leukemia.
Lian LJ; Lin B; Cui X; He J; Wang Z; Lin XD; Ye WJ; Chen RJ; Sun W
Drug Des Devel Ther; 2020; 14():4835-4843. PubMed ID: 33204069
[TBL] [Abstract][Full Text] [Related]
30. Urine biomonitoring of occupational exposure to methotrexate using a highly sensitive UHPLC-MS/MS method in MRM
Villa A; Tremolet K; Martinez B; Petit M; Dascon X; Stanek J; Ducint D; Titier-Debeaupuis K; Verdun-Esquer C; Molimard M; Canal-Raffin M
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1209():123411. PubMed ID: 35985163
[TBL] [Abstract][Full Text] [Related]
31. Using fluorescence polarization immunoassay for determination of erythrocyte methotrexate polyglutamates, a quick and easy test?
den Boer E; Koch BC; Huisman R; de Jonge R
Ther Drug Monit; 2014 Dec; 36(6):819-23. PubMed ID: 24739667
[TBL] [Abstract][Full Text] [Related]
32. Determination of methotrexate and its major metabolite 7-hydroxymethotrexate in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry.
Guo P; Wang X; Liu L; Belinsky MG; Kruh GD; Gallo JM
J Pharm Biomed Anal; 2007 Apr; 43(5):1789-95. PubMed ID: 17289326
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous determination of low levels of methotrexate and cyclophosphamide in human urine by micro liquid chromatography/electrospray ionization tandem mass spectrometry.
Barbieri A; Sabatini L; Indiveri P; Bonfiglioli R; Lodi V; Violante FS
Rapid Commun Mass Spectrom; 2006; 20(12):1889-93. PubMed ID: 16715479
[TBL] [Abstract][Full Text] [Related]
34. Effect of total glucosides of paeony and Tripterygium wilfordii polyglycosides on erythrocyte methotrexate polyglutamates in rats, analysed using ultra-high-performance liquid chromatography-tandem mass spectrometry.
Wu S; Mo L; Ye C; Xun T; Wang X; Lv B; Zhan X; Liu B; Ding Q; Peng J; Chen C; Yang X
J Pharm Pharmacol; 2021 Jul; 73(8):1039-1048. PubMed ID: 33749788
[TBL] [Abstract][Full Text] [Related]
35. High-performance liquid chromatographic analysis of MTX, 7-OH-MTX and MTX derivatives: application to intracellular metabolism in tumor cells (HT 29).
Durand R; Fabre G; Cano JP; Catalin J; Ahmed OA; Just S
J Appl Toxicol; 1983 Aug; 3(4):189-95. PubMed ID: 6196390
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue.
Wolfrom C; Hepp R; Hartmann R; Breithaupt H; Henze G
Eur J Clin Pharmacol; 1990; 39(4):377-83. PubMed ID: 2076721
[TBL] [Abstract][Full Text] [Related]
37. Monitoring methotrexate in clinical samples from cancer patients during chemotherapy with a LSPR-based competitive sensor.
Zhao SS; Bichelberger MA; Colin DY; Robitaille R; Pelletier JN; Masson JF
Analyst; 2012 Oct; 137(20):4742-50. PubMed ID: 22943049
[TBL] [Abstract][Full Text] [Related]
38. The influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination.
Klapkova E; Kukacka J; Kotaska K; Suchanska I; Urinovska R; Prusa R
Clin Lab; 2011; 57(7-8):599-606. PubMed ID: 21888024
[TBL] [Abstract][Full Text] [Related]
39. Kinetics of 7-hydroxy-methotrexate after high-dose methotrexate therapy.
Erttmann R; Bielack S; Landbeck G
Cancer Chemother Pharmacol; 1985; 15(2):101-4. PubMed ID: 3874719
[TBL] [Abstract][Full Text] [Related]
40. Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
Heuschkel S; Kretschmann T; Teipel R; von Bonin S; Richter S; Quick S; Alakel N; Röllig C; Balaian E; Kroschinsky F; Knoth H; Bornhäuser M; von Bonin M
Cancer Chemother Pharmacol; 2022 Jan; 89(1):41-48. PubMed ID: 34669022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
